MIT Center for Biomedical Innovation

Ensuring ACCESS TO SAFE AND EFFECTIVE MEDICINES FOR ALL is a complex challenge that requires innovation and collaboration.
MIT CBI is a COLLABORATION ENGINE that brings together the excellence of MIT researchers with stakeholders across the healthcare value chain.
Collaboratively, MIT CBI DESIGNS, TESTS, and IMPLEMENTS ways to ensure global access to safe and effective medicines.

CBI provides integrated solutions to global health

CBI Activities

Collaboration

MIT CBI is home to the Biomanufacturing Consortium (BioMAN), and the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB). These pre-competitive programs provide a safe haven where industry, academia, and government collaboratively address challenges in manufacturing, delivery, and access to biologics through focused events and projects that address key challenges in biomanufacturing.

See our Collaboration

Education

MIT CBI has developed a number of biomanufacturing-related educational offerings including a residential MIT course, an on-line course on the principles of manufacturing protein and antibody drugs, and a short course on vaccine manufacturing offered jointly with University College London. We have developed a blended learning course for the training of cell therapy manufacturing personnel which will combine online learning with hands-on training.

See our Education

Research

MIT CBI research projects focus on biomanufacturing process innovation for production of biologic medicines including monoclonal antibodies, vaccines, viral vectors, and cell therapies. Our main research areas include process analytical technologies, biomanufacturing data analytics, advanced process modeling and control, and continuous manufacturing.

See our Research

Upcoming Events

Oct

28

CAACB Fall 2025 Workshop

From October 28, 2025 to October 29, 2025

MIT Schwarzman College of Computing, 51 Vassar St, Cambridge, MA 02139

Dec

09

2025 BioMAN Summit

From December 9, 2025 to December 10, 2025

Samberg Conference Center, 50 Memorial Drive, Cambridge MA

View All Events

Latest News & Research

CAACB Publishes on NGS

The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) collected historical data from 20 biopharmaceutical industry members on their…
New leadership at MIT’s Center for Biomedical Innovation

Stacy Springs named Executive Director, Richard Braatz named Associate Faculty Director. Read the announcement via MIT News HERE.
SMART researchers enable early-stage detection of microbial contamination in cell therapy

Researchers from the Singapore-MIT Alliance for Research and Technology (SMART), MIT’s research enterprise in Singapore, have identified a critical quality…

View All News

Our Team

CBI’s core strength is in our team’s cross-cutting experience and expertise in medicine, biology, chemistry, biomanufacturing, academic & clinical research, economics, engineering, data analytics, regulatory science and public policy.

Meet the Team

Our Members

Our members and collaborators are leading stakeholders across the global healthcare value chain, from R&D and manufacturing to delivery and reimbursement.